News Mind Medicine Australia to supply medical psilocybin and MDMA for clinical trials at no cost It is particularly interested in supporting research that optimizes treatment results and extends the application of psychedelic-assisted therapies Natalia Buendia CalvilloMay 18, 2023
News Optimi Health completes harvesting psilocybin mushrooms for Australia-bound medical extract Australia will allow psychiatrists to prescribe psilocybin and MDMA for certain conditions as of July 1 Natalia Buendia CalvilloMay 17, 2023
Psychedelics PharmAla Biotech first to get Special Access Program authorization for its MDMA Health Canada granted PharmAla approval to provide its LaNeo product to a physician that will facilitate MDMA-assisted therapy Rowan DunneMay 16, 2023
Psychedelics Optimi Health enters $1.2M psilocybin distribution agreement The mushroom cultivator will be supplying a private client for clinical research purposes Rowan DunneMay 4, 2023
News PharmAla Biotech and Vitura Health form joint psychedelics venture in Australia To help the new venture get started, Vitura has agreed to provide up to $2.2 million in loans Natalia Buendia CalvilloMay 2, 2023
Psychedelics Incannex orders psilocybin and MDMA from PharmAla Biotech Incannex plans to open a series of psychedelics clinics in Australia and use PharmAla's products Rowan DunneApril 25, 2023
Psychedelics International psychedelics market to reach US$8.31B by 2027: Report Linker The market was valued at US$4.83B this year and will rise with a CAGR of 14.5 per cent Rowan DunneApril 24, 2023
Psychedelics Mydecine’s MDMA with rapid onset and a short duration shows promising results The effects from the company's MYCO-006 compounds last for only two hours and set in four times as fast Rowan DunneApril 24, 2023
Medical and Pharmaceutical PharmAla Biotech and Filament Health partner to release MDMA capsules The capsules are GMP certified and will be used in clinical trials and by authorized patients Natalia Buendia CalvilloApril 11, 2023
Psychedelics Dutch government establishes MDMA research commission The commission will be investigating the risks and benefits associated with MDMA-assisted therapy Rowan DunneMarch 31, 2023